SF Healthcare Week: Bausch + Lomb Chairman & CEO Brent Saunders covers the company's pharmaceutical pipeline for the eye
- blonca9
- 5 hours ago
- 1 min read
He discusses programs covering dry eye, ocular pain, AMD, geographic atrophy, and more. Plus, how he using Bausch + Lomb's expertise in the eye and investing in biotech technologies of the future.











.png)

